GOSS RSI Chart
Last 7 days
-21.3%
Last 30 days
-41.8%
Last 90 days
-8.6%
Trailing 12 Months
-18.7%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2022 | 966.5K | 1.2M | 1.4M | 1.6M |
2021 | 2.8M | 2.1M | 1.4M | 761.0K |
2020 | 5.0M | 4.5M | 4.0M | 3.4M |
2019 | 0 | 0 | 0 | 5.6M |
2018 | 0 | 0 | 0 | 1.7M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 27, 2024 | hasnain faheem | sold | -26,772 | 1.1554 | -23,172 | president & ceo |
Mar 27, 2024 | christian waage | sold | -7,429 | 1.1555 | -6,430 | evp, tech ops and admin |
Mar 27, 2024 | giraudo bryan | sold | -7,430 | 1.1556 | -6,430 | coo/cfo |
Mar 18, 2024 | peterson caryn | sold | -5,342 | 1.3297 | -4,018 | evp, regulatory affairs |
Mar 18, 2024 | aranda richard | sold | -5,341 | 1.3295 | -4,018 | chief medical officer |
Nov 15, 2023 | milligan sandra | bought | 25,212 | 0.7879 | 32,000 | - |
Nov 13, 2023 | giraudo bryan | bought | 112,880 | 0.5644 | 200,000 | coo/cfo |
Jul 24, 2023 | giraudo bryan | acquired | 98,316 | 1.82 | 54,020 | coo/cfo |
Jul 24, 2023 | hasnain faheem | acquired | 983,120 | 1.82 | 540,176 | president & ceo |
Jul 24, 2023 | christian waage | acquired | 24,577 | 1.82 | 13,504 | evp, tech ops and admin |
Which funds bought or sold GOSS recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Apr 12, 2024 | waypoint wealth counsel | sold off | -100 | -10,730 | - | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 3.26 | 1,233,250 | 10,617,500 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | added | 227 | 3,589,210 | 4,975,410 | -% |
Feb 27, 2024 | Beaird Harris Wealth Management, LLC | sold off | -100 | -62.00 | - | -% |
Feb 26, 2024 | Virtu Financial LLC | new | - | 30,000 | 30,000 | -% |
Feb 16, 2024 | Madison Avenue Partners, LP | reduced | -17.55 | -493,081 | 4,612,210 | 0.65% |
Feb 16, 2024 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | new | - | 18,889 | 18,889 | -% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | new | - | 3,372,000 | 3,372,000 | -% |
Feb 15, 2024 | BARCLAYS PLC | reduced | -50.00 | - | - | -% |
Feb 15, 2024 | SPHERA FUNDS MANAGEMENT LTD. | reduced | -30.76 | -388,436 | 1,221,010 | 0.20% |
Unveiling Gossamer Bio Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Gossamer Bio Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 39.7B | 6.8B | -8.42 | 5.79 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 18.6B | 1.8B | -42.25 | 10.17 | ||||
BMRN | 17.3B | 2.4B | 103 | 7.14 | ||||
INCY | 12.0B | 3.7B | 20.07 | 3.25 | ||||
MID-CAP | ||||||||
APLS | 6.2B | 396.6M | -11.74 | 15.65 | ||||
BBIO | 4.5B | - | -6.94 | 60.35 | ||||
AXSM | 3.2B | 270.6M | -13.52 | 11.95 | ||||
ARWR | 3.0B | 240.7M | -10.03 | 12.36 | ||||
ACAD | 2.8B | 726.4M | -45.41 | 3.83 | ||||
SMALL-CAP | ||||||||
CPRX | 1.8B | 398.2M | 25.42 | 4.56 | ||||
NVAX | 576.6M | 983.7M | -1.06 | 0.59 | ||||
CRBP | 448.6M | 881.7K | -10.06 | 466.16 | ||||
INO | 256.8M | 4.9M | -1.9 | 52.78 | ||||
IBIO | 6.7M | 2.1M | -0.25 | 2.14 |
Gossamer Bio Inc News
Income Statement (Quarterly) | |||||||||||||||
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Operating Expenses | -3.0% | 54,357,000 | 56,021,000 | 53,872,000 | 54,343,000 | 51,661,000 | 55,664,000 | 55,596,000 | 53,203,000 | 60,087,000 | 53,569,000 | 65,339,000 | 54,967,000 | 55,787,500 | 39,807,000 |
S&GA Expenses | 11.6% | 12,834,000 | 11,497,000 | 11,277,000 | 12,001,000 | 10,714,000 | 12,459,000 | 11,263,000 | 11,346,000 | 15,877,000 | 11,448,000 | 11,655,000 | 10,748,000 | 11,591,500 | 13,935,000 |
EBITDA Margin | - | - | - | -282 | -281 | -279 | - | - | -65.41 | -66.61 | -30.55 | -31.17 | -31.57 | -31.90 | -85.27 |
Interest Expenses | -0.5% | 3,457,000 | 3,475,000 | 3,481,000 | 3,467,000 | 4,937,000 | 4,889,000 | 4,834,000 | 4,780,000 | 4,753,000 | 4,715,000 | 2,491,000 | 707,000 | 1,084,000 | - |
EBT Margin | - | - | - | -307 | -307 | -307 | - | - | -70.70 | -70.70 | -32.41 | -32.41 | -32.41 | -32.41 | -85.45 |
Net Income | 6.1% | -55,764,000 | -59,363,000 | -56,466,000 | -57,785,000 | -56,284,000 | -60,247,000 | -59,832,000 | -57,641,000 | -64,604,000 | -57,812,000 | -66,870,000 | -54,074,000 | -54,698,000 | -38,794,000 |
Net Income Margin | 13.2% | -144 | -166 | -196 | -242 | -307 | -169 | -114 | -89.09 | - | - | - | - | - | - |
Free Cashflow | -29.2% | -47,832,000 | -37,028,000 | -48,942,000 | -53,640,000 | -40,592,000 | -42,558,000 | -47,588,000 | -59,698,000 | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -10.3% | 312 | 348 | 182 | 220 | 272 | 324 | 246 | 295 | 344 | 387 | 433 | 482 | 539 | 584 | 625 | 371 | 427 | 470 | 507 | 516 | 239 |
Current Assets | -10.2% | 307 | 341 | 173 | 210 | 262 | 312 | 233 | 281 | 332 | 374 | 417 | 466 | 522 | 566 | 608 | 355 | 409 | 452 | 490 | 498 | 232 |
Cash Equivalents | -61.1% | 32.00 | 83.00 | 37.00 | 65.00 | 112 | 153 | 94.00 | 139 | 183 | 214 | 343 | 440 | 487 | 462 | 486 | 111 | 135 | 131 | 149 | 171 | 105 |
Net PPE | -15.1% | 2.00 | 2.00 | 3.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 6.00 | 5.00 | 5.00 | 5.00 | 4.00 | 3.00 |
Liabilities | 2.4% | 249 | 243 | 245 | 248 | 260 | 267 | 262 | 265 | 222 | 217 | 212 | 210 | 219 | 212 | 205 | 65.00 | 74.00 | 71.00 | 66.00 | 36.00 | 21.00 |
Current Liabilities | 21.9% | 52.00 | 42.00 | 40.00 | 41.00 | 49.00 | 53.00 | 44.00 | 35.00 | 40.00 | 36.00 | 30.00 | 29.00 | 39.00 | 33.00 | 28.00 | 28.00 | 37.00 | 33.00 | 28.00 | 25.00 | 20.00 |
Long Term Debt | -100.0% | - | 4.00 | 6.00 | 9.00 | 12.00 | 15.00 | 18.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | - | - |
LT Debt, Current | 0% | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -77.6% | 1.00 | 4.00 | 6.00 | 9.00 | 12.00 | 15.00 | 18.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 29.00 | 28.00 | 28.00 | 28.00 | - | - |
Shareholder's Equity | -40.0% | 63.00 | 105 | - | - | 12.00 | 56.00 | - | 30.00 | 121 | 170 | 221 | 272 | 321 | 372 | 420 | 306 | 352 | 399 | 441 | 480 | - |
Retained Earnings | -4.1% | -1,212 | -1,163 | -1,123 | -1,081 | -1,032 | -976 | -917 | -860 | -811 | -755 | -695 | -635 | -577 | -512 | -455 | -388 | -334 | -279 | -230 | -186 | -153 |
Additional Paid-In Capital | 0.5% | 1,275 | 1,269 | 1,062 | 1,053 | 1,045 | 1,033 | 901 | 891 | 933 | 925 | 915 | 907 | 898 | 885 | 875 | 695 | 686 | 678 | 672 | 667 | 34.00 |
Shares Outstanding | 0% | 225 | 225 | 95.00 | 95.00 | 94.00 | 81.00 | 77.00 | 76.00 | 76.00 | 75.00 | 74.00 | 74.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 541 | - | - | - | 517 | - | - | - | 775 | - | - | - | 948 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 3.1% | -33,424 | -34,494 | -38,251 | -52,989 | -47,730 | -36,997 | -48,822 | -53,483 | -40,509 | -42,035 | -47,450 | -58,896 | -36,736 | -44,930 | -42,399 | -52,295 | -44,140 | -36,110 | -36,810 | -27,774 | -25,023 |
Share Based Compensation | -2.1% | 6,032 | 6,162 | 8,197 | 8,127 | 11,449 | 10,122 | 9,999 | 10,983 | 7,659 | 7,587 | 8,054 | 8,708 | 12,681 | 8,923 | 8,900 | 8,244 | 6,862 | 5,728 | 5,140 | 3,089 | 10,799 |
Cashflow From Investing | 87.9% | -14,366 | -118,262 | 12,936 | 8,722 | 8,464 | -22,598 | 4,679 | 8,420 | 10,443 | -89,762 | -50,076 | 11,968 | 61,100 | 19,959 | 106,245 | 28,038 | 46,933 | 17,949 | -13,884 | -198,142 | -8,681 |
Cashflow From Financing | -101.5% | -2,903 | 198,497 | -2,904 | -2,536 | -2,873 | 119,221 | 21.00 | 721 | 371 | 1,913 | 271 | 774 | 249 | 891 | 310,829 | 571 | 1,518 | 369 | 28,347 | 291,344 | -2,144 |
Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Operating expenses: | |||
Research and development | $ 135,304 | $ 170,919 | $ 170,267 |
In process research and development | 10,000 | 65 | 75 |
General and administrative | 38,455 | 47,609 | 45,782 |
Total operating expenses | 183,759 | 218,593 | 216,124 |
Loss from operations | (183,759) | (218,593) | (216,124) |
Other income (expense) | |||
Interest income | 1,997 | 1,583 | 761 |
Interest expense | (13,511) | (13,880) | (19,440) |
Other income, net | 15,456 | 1,512 | 799 |
Total other income (expense), net | 3,942 | (10,785) | (17,880) |
Net loss | (179,817) | (229,378) | (234,004) |
Other comprehensive (loss) income: | |||
Foreign currency translation | 33 | (544) | (329) |
Unrealized income (loss) on marketable securities | 191 | (75) | (225) |
Other comprehensive income (loss) | 224 | (619) | (554) |
Comprehensive loss | $ (179,593) | $ (229,997) | $ (234,558) |
Net loss per share, basic (in dollars per share) | $ (1.18) | $ (2.71) | $ (3.13) |
Net loss per share, diluted (in dollars per share) | $ (1.18) | $ (2.71) | $ (3.13) |
Weighted average common shares outstanding, basic (in shares) | 152,621,669 | 84,574,869 | 74,843,482 |
Weighted average common shares outstanding, diluted (in shares) | 152,621,669 | 84,574,869 | 74,843,482 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets | ||
Cash and cash equivalents | $ 32,109 | $ 111,973 |
Marketable securities | 264,316 | 143,705 |
Prepaid expenses and other current assets | 10,094 | 6,202 |
Total current assets | 306,519 | 261,880 |
Property and equipment, net | 1,648 | 3,981 |
Operating lease right-of-use assets | 3,131 | 5,909 |
Other assets | 618 | 680 |
Total assets | 311,916 | 272,450 |
Current liabilities | ||
Accounts payable | 5,526 | 1,459 |
Accrued research and development expenses | 7,779 | 15,626 |
Current portion of long-term debt | 11,613 | 11,613 |
Accrued expenses and other current liabilities | 26,680 | 20,532 |
Total current liabilities | 51,598 | 49,230 |
Long-term convertible senior notes | 196,591 | 195,709 |
Long-term debt | 814 | 11,988 |
Operating lease liabilities - long-term | 144 | 3,446 |
Total liabilities | 249,147 | 260,373 |
Commitments and contingencies (Note 11) | ||
Stockholders' equity (deficit) | ||
Common stock, $0.0001 par value; 700,000,000 shares authorized as of December 31, 2023 and December 31, 2022; 225,409,315 shares issued and outstanding as of December 31, 2023, and 94,478,405 shares issued and 94,423,181 shares outstanding as of December 31, 2022 | 23 | 10 |
Additional paid-in capital | 1,275,136 | 1,044,864 |
Accumulated deficit | (1,212,040) | (1,032,223) |
Accumulated other comprehensive loss | (350) | (574) |
Total stockholders' equity | 62,769 | 12,077 |
Total liabilities and stockholders' equity | $ 311,916 | $ 272,450 |